Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
NCT05254314 · active not recruiting · No results posted in this snapshot
All research
COMPOUND RESEARCH
Semaglutide
Follow the papers. Understand the context.
16 papers · 8 trial recordsChecked 18 Sept 2026
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease.
Diabetes, obesity & metabolism · Abstract available
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
NCT06913023 · not yet recruiting · No results posted in this snapshot
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
NCT07639021 · active not recruiting · No results posted in this snapshot
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.
JAMA cardiology · Abstract available
When dose follows response: Interpreting lower-dose semaglutide effectiveness in clinical practice.
Diabetic medicine : a journal of the British Diabetic Association · Citation only
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06045221 · completed · Results posted
Improvement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review.
Hormones (Athens, Greece) · Abstract available
Postoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis.
The Knee · Abstract available
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update.
Gut · Abstract available
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
NCT06797869 · completed · No results posted in this snapshot
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
NCT07010432 · recruiting · No results posted in this snapshot
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
NCT07184086 · active not recruiting · No results posted in this snapshot
Reduced Risk in Melanoma and Nonmelanoma Skin Cancers in Obese Patients on Semaglutide and Tirzepatide.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · Citation only
Wegovy: GPs are told not to prescribe GLP semaglutide for heart health without funding guarantee.
BMJ (Clinical research ed.) · Citation only
Carbon Emission Impact of Semaglutide in People with Obesity in the UK Using a Disease Modelling Approach.
PharmacoEconomics · Abstract available
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
NCT06323161 · completed · No results posted in this snapshot
Semaglutide and Tirzepatide for the treatment of MASH: What Works, What's Coming, and What's Missing.
Digestion · Abstract available
Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.
iScience · Abstract available
Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
Lancet (London, England) · Abstract available
Cagrilintide-semaglutide: a new option for patients with type 2 diabetes.
The lancet. Diabetes & endocrinology · Citation only
Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.
The lancet. Diabetes & endocrinology · Abstract available
Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study.
The lancet. Diabetes & endocrinology · Abstract available
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial.
The lancet. Diabetes & endocrinology · Abstract available
Publications match compound names in their titles. Trial matches use intervention names. An association with a compound is not a finding about its effectiveness. How we select records.